BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24809468)

  • 1. The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target.
    Orlandini M; Galvagni F; Bardelli M; Rocchigiani M; Lentucci C; Anselmi F; Zippo A; Bini L; Oliviero S
    Oncotarget; 2014 May; 5(9):2750-60. PubMed ID: 24809468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration adhesion and migration.
    Galvagni F; Nardi F; Maida M; Bernardini G; Vannuccini S; Petraglia F; Santucci A; Orlandini M
    Oncotarget; 2016 Mar; 7(9):10090-103. PubMed ID: 26848865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
    Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
    Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells.
    Barbera S; Raucci L; Lugano R; Tosi GM; Dimberg A; Santucci A; Galvagni F; Orlandini M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.
    Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M
    Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration.
    Barbera S; Nardi F; Elia I; Realini G; Lugano R; Santucci A; Tosi GM; Dimberg A; Galvagni F; Orlandini M
    Cell Commun Signal; 2019 May; 17(1):55. PubMed ID: 31138217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.
    Bao L; Tang M; Zhang Q; You B; Shan Y; Shi S; Li L; Hu S; You Y
    Biochem Biophys Res Commun; 2016 Aug; 476(4):467-474. PubMed ID: 27255994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
    Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
    Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidermal growth factor-like domain of CD93 is a potent angiogenic factor.
    Kao YC; Jiang SJ; Pan WA; Wang KC; Chen PK; Wei HJ; Chen WS; Chang BI; Shi GY; Wu HL
    PLoS One; 2012; 7(12):e51647. PubMed ID: 23272129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells.
    Dai F; Chen Y; Song Y; Huang L; Zhai D; Dong Y; Lai L; Zhang T; Li D; Pang X; Liu M; Yi Z
    PLoS One; 2012; 7(12):e52162. PubMed ID: 23300602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis.
    Lee WS; Pyun BJ; Kim SW; Shim SR; Nam JR; Yoo JY; Jin Y; Jin J; Kwon YG; Yun CO; Nam DH; Oh K; Lee DS; Lee SH; Yoo JS
    MAbs; 2015; 7(5):957-68. PubMed ID: 25942475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
    Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
    J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization.
    Tosi GM; Neri G; Barbera S; Mundo L; Parolini B; Lazzi S; Lugano R; Poletto E; Leoncini L; Pertile G; Mongiat M; Dimberg A; Galvagni F; Orlandini M
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):30. PubMed ID: 32697305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic Activity of Acer tegmentosum Maxim Water Extract in Vitro and in Vivo.
    Kim EC; Kim SH; Piao SJ; Kim TJ; Bae K; Kim HS; Hong SS; Lee BI; Nam M
    J Korean Med Sci; 2015 Jul; 30(7):979-87. PubMed ID: 26130964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood.
    Ikewaki N; Yamao H; Kulski JK; Inoko H
    J Clin Immunol; 2010 Sep; 30(5):723-33. PubMed ID: 20512406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth.
    Yan X; Lin Y; Yang D; Shen Y; Yuan M; Zhang Z; Li P; Xia H; Li L; Luo D; Liu Q; Mann K; Bader BL
    Blood; 2003 Jul; 102(1):184-91. PubMed ID: 12609848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Antiangiogenic Efficacy of Emilia sonchifolia (L.) DC on Tumor-Specific Neovessel Formation by Regulating MMPs, VEGF, and Proinflammatory Cytokines.
    Gilcy GK; Kuttan G
    Integr Cancer Ther; 2016 Dec; 15(4):NP1-NP12. PubMed ID: 27146127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.